Search details
1.
Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation.
Immunity
; 48(2): 339-349.e5, 2018 02 20.
Article
in English
| MEDLINE | ID: mdl-29396163
2.
Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.
J Virol
; 91(15)2017 08 01.
Article
in English
| MEDLINE | ID: mdl-28539444
3.
Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
J Virol
; 90(21): 10022-10038, 2016 Nov 01.
Article
in English
| MEDLINE | ID: mdl-27581977
4.
Human amniotic fluid antibodies protect the neonate against respiratory syncytial virus infection.
J Allergy Clin Immunol
; 138(5): 1477-1480.e5, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27448445
5.
Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors.
Sci Immunol
; 1(6)2016 Dec 16.
Article
in English
| MEDLINE | ID: mdl-28111638
6.
Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus.
PLoS One
; 11(7): e0159709, 2016.
Article
in English
| MEDLINE | ID: mdl-27463224
7.
Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera.
Sci Transl Med
; 7(309): 309ra162, 2015 Oct 14.
Article
in English
| MEDLINE | ID: mdl-26468324
Results
1 -
7
de 7
1
Next >
>>